TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions, Inc. develops and commercializes disinfection and decontamination technologies for use in controlled environments and public spaces. Its business centers on hydrogen peroxide-based systems and related application methods sold into healthcare, life sciences, food safety, and other contamination-sensitive settings in the United States and international markets.

−63,6 %

54,6 %

−66,5 %

−27,2 %

1.32

0.40

— TOMI Environmental Solutions, Inc.
%
Disinfection systems45% Equipment and systems used to apply TOMI's disinfection technology in rooms, surfaces, and enclosed spaces.
Consumables and accessories20% Replacement parts, consumables, and application components used with installed systems.
Service and decontamination work25% Direct disinfection, decontamination, and application services performed for customers.
Licensing and other revenue10% Other commercial arrangements tied to the company's proprietary technology and related offerings.

TOMI sells to organizations that need validated disinfection and contamination control, especially where hygiene...

  • Healthcareprimary

    Hospitals and clinical facilities buy disinfection systems and services for patient rooms, equipment, and high-touch areas.

  • Life sciences and laboratoriesprimary

    Labs and research facilities use the technology to reduce contamination risk in controlled environments.

  • Pharmaceutical and biotechsecondary

    Manufacturers and cleanroom operators buy decontamination solutions to support sterile operations.

  • Food and beveragesecondary

    Processors and related facilities use sanitation solutions to support hygiene and compliance.

  • Commercial and institutionalemerging

    Schools, offices, transportation, and other public venues may purchase disinfection systems or services.

The company is based in the United States and serves domestic customers as well as international markets through...

  • United States is the core operating and customer base
  • International sales expand the addressable market for SteraMist
  • Healthcare and lab density influences regional demand
  • Distribution and service reach affect adoption outside the U.S.

TOMI's strategy is centered on commercializing its proprietary disinfection platform across regulated and...

01
Commercialize proprietary disinfection technologyshort-term

A differentiated technology platform can support customer adoption and pricing power versus commodity cleaning products.

02
Increase recurring revenue mixmedium-term

Consumables and service work can create repeat demand after initial system placement.

03
Expand into regulated end marketsmedium-term

Healthcare, labs, and pharma customers have persistent contamination-control needs and higher switching costs.

TOMI depends on customer adoption of a specialized technology platform, so demand can be uneven and tied to capital...

high

Customer adoption and demand variability

The business depends on customers choosing a specialized disinfection platform rather than standard cleaning or competing technologies.

Scope
Healthcare, labs, pharma, food safety
Materiality
high
high

Small-company execution risk

A niche commercial model requires effective sales, installation, and service execution to convert pipeline into revenue.

Scope
Company-wide
Materiality
high
medium

Competitive substitution

Alternative disinfectants, UV systems, and contract cleaning providers can reduce demand for TOMI's systems and services.

Scope
All end markets
Materiality
high
medium

Regulatory and validation burden

Customers in regulated environments often require proof of efficacy and compliance before adoption.

Scope
Healthcare and life sciences
Materiality
medium
Revenue recognition by product and service type
Reported revenue mix and timing
Convertible promissory notes
Debt balance, interest expense, and potential dilution
Allowance for doubtful accounts
Net revenue and receivables
Inventory and equipment valuation
Gross margin and asset values

: 29/04/2026